Posted on 1/29/20
MTBC’s CareCloud Appoints Luma Health as Newest Partner
SOMERSET, N.J, Jan. 28, 2020 (GLOBE NEWSWIRE) -- MTBC, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of cloud-based healthcare IT and revenue cycle management solutions, . . .
Posted on 1/28/20
Outlook Therapeutics Announces Agreements to Streamline Capital Structure
CRANBURY, N.J., Jan. 28, 2020 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ: OTLK), a?late clinical-stage?biopharmaceutical company?working to develop the first FDA-approved ophthalmic formulation of bevacizumab?for use . . .
Posted on 1/28/20
STEALTHbits Enters 2020 With an Expanded Sales Team and Aggressive Growth Plans
HAWTHORNE, N.J.--(BUSINESS WIRE)--STEALTHbits Technologies, Inc., a cybersecurity software company focused on protecting an organization’s sensitive data and the credentials attackers use to steal that data, has . . .
Posted on 1/28/20
FDA Approves Merck's Dificid for Infections in Children
The U.S. Food and Drug Administration approved Merck's (NYSE:MRK) Dificid drug for children aged 6 months and older who have diarrhea caused by a specific bacterial . . .
Posted on 1/28/20
The Vitamin Shoppe Opens New Distribution Channel in Partnership with LA Fitness
The Vitamin Shoppe®, an omni-channel specialty retailer of nutritional products, announced today a partnership with LA Fitness that opens The Vitamin Shoppe locations inside LA Fitness . . .
Posted on 1/27/20
electroCore Announces Rebate Agreement with Ascent Health Services
BASKING RIDGE, N.J., Jan. 27, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Ascent Health Services on behalf . . .
Posted on 1/27/20
Antares Pharma Announces Full-Year 2020 Net Revenue Guidance Range of $135 to $155 Million
EWING, N.J., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (The Company) today announced 2020 full-year net revenue guidance of $135 to $155 . . .
Posted on 1/27/20
Better Buy: AbbVie vs. Johnson & Johnson
AbbVie (NYSE:ABBV) and Johnson & Johnson (NYSE:JNJ) are two of the largest pharmaceutical companies in the world. However, big doesn't mean buy, and both of these . . .
Posted on 1/27/20
An Emboldened Bristol-Myers Squibb Wants $1.5 Billion From Gilead Sciences
Last year, Bristol-Myers Squibb (NYSE:BMY) spent $74 billion for Celgene and its mixed bag of commercial and clinical-stage drugs. Analysts are still arguing about whether the . . .
Posted on 1/27/20
Applied Therapeutics Announces Upsizing and Pricing of Public Offering of Common Stock
NEW YORK, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated . . .
Posted on 1/24/20
Bristol-Myers Squibb: The Merger Is Complete, Time To Shine
SummaryBristol-Myers Squibb has finally completed the acquisition of Celgene, now is the time to shine.The company performed incredibly well in 2019 - better than it originally . . .
Posted on 1/24/20
Should Investors Be Worried About Merck's Keytruda?
Merck's (NYSE:MRK) cancer immunology drug, Keytruda, is already one of the best-selling drugs in the world and is well on track to becoming the No. 1 . . .
Posted on 1/24/20
Pfizer to Market Viagra Through Roman's Telehealth Service
Pfizer (NYSE:PFE) will provide patients of Roman, a men's health subsidiary of the privately held digital health company Ro, with the only Pfizer-authorized generic version of . . .
Posted on 1/23/20
Johnson & Johnson's Fourth-Quarter Results Leave Wall Street With Mixed Emotions
Johnson & Johnson (NYSE:JNJ) kicked off another earnings season with fourth-quarter results that missed analysts' consensus estimates on the top line, but contained enough positive surprises . . .
Posted on 1/23/20
Quest Diagnostics Buys Blueprint Genetics to Help It Read Mountains of DNA Data
Quest Diagnostics (NYSE:DGX) runs medical tests on one in three American adults each year, and there are treasure chests full of medical insights buried in the . . .
Posted on 1/22/20
MetLife Named to ‘World’s Most Admired Companies’ List by Fortune Magazine
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has been named to Fortune magazine’s 2020 list of the “World’s Most Admired Companies.” Seven life . . .
Posted on 1/22/20
AstraZeneca and Merck Get an FDA Priority Review for Lynparza in Prostate Cancer
AstraZeneca (NYSE:AZN) and Merck (NYSE:MRK) continue their quest to gain additional approvals for their blockbuster cancer drug Lynparza. The duo submitted a new application to the . . .
Posted on 1/22/20
FDA Puts GlaxoSmithKline's Blood Cancer Drug In the Fast Lane
GlaxoSmithKline's (NYSE:GSK) experimental new cancer drug, belantamab mafodotin, will receive a priority review from the U.S. Food and Drug Administration. The agency's recent decision means belantamab . . .
Posted on 1/22/20
Merck's Keytruda Could Face Direct Competition from New Chinese Drug
Chinese drug developer BeiGene (NASDAQ:BGNE) announced on Monday strong clinical results for its cancer immunotherapy, tislelizumab. A Phase 3 trial tested the drug alongside two other . . .
Posted on 1/22/20
Quest Diagnostics Named One of 2020 "World's Most Admired Companies" by FORTUNE Magazine for Sixth Consecutive Year
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired . . .
Posted on 1/22/20
Applied Therapeutics Announces Offering of 1,750,000 Shares of Common Stock
NEW YORK, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated . . .
Posted on 1/21/20
Advaxis Prices $10.5M Registered Direct Offering
PRINCETON, N.J., Jan. 21, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today . . .
Posted on 1/21/20
MTF Biologics Announces Partnership With Net Health Wound Care EMR
EDISON, N.J.--(BUSINESS WIRE)--MTF Biologics, a global nonprofit organization dedicated to saving and healing lives through organ and tissue donation, today announced a partnership with Net Health, . . .
Posted on 1/21/20
Hitachi Chemical Advanced Therapeutics Solutions and Ori Biotech Announce a Joint Development Agreement
ALLENDALE, N.J.--(BUSINESS WIRE)--Hitachi Chemical Advanced Therapeutics Solutions, LLC (HCATS), a US subsidiary of Hitachi Chemical Co., Ltd. that engages in contract manufacturing and manufacturing development of . . .
Posted on 1/21/20
OncoHost and RayBiotech Awarded $1 Million Grant From the BIRD Foundation to Advance Precision Oncology for Patients Receiving Immunotherapy
OncoHost, global leader in host response profiling for improved personalized cancer therapy, together with its partner RayBiotech, a leading life sciences company developing high-throughput protein detection . . .
New York
